Cameron Herberts

1.3k total citations
20 papers, 445 citations indexed

About

Cameron Herberts is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Cameron Herberts has authored 20 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Cameron Herberts's work include Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (12 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Cameron Herberts is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (12 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Cameron Herberts collaborates with scholars based in Canada, Finland and United States. Cameron Herberts's co-authors include Alexander W. Wyatt, Matti Annala, Gillian Vandekerkhove, Kim N., Evan W. Warner, Elie Ritch, Kevin Beja, Daniel Khalaf, Martin Gleave and Matti Nykter and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Cameron Herberts

17 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cameron Herberts Canada 10 319 242 123 122 91 20 445
Elie Ritch Canada 7 320 1.0× 284 1.2× 141 1.1× 147 1.2× 172 1.9× 13 501
Gianluca Gragnano Italy 11 212 0.7× 201 0.8× 159 1.3× 101 0.8× 22 0.2× 20 336
Sergi Clavé Spain 10 221 0.7× 117 0.5× 207 1.7× 76 0.6× 37 0.4× 26 365
Mariantonia Nacchio Italy 12 232 0.7× 207 0.9× 183 1.5× 137 1.1× 51 0.6× 31 433
J.B. Auliac France 15 604 1.9× 161 0.7× 433 3.5× 121 1.0× 79 0.9× 64 741
Adam Szpechciński Poland 11 200 0.6× 308 1.3× 127 1.0× 226 1.9× 24 0.3× 32 469
Yalun Li China 12 163 0.5× 89 0.4× 164 1.3× 117 1.0× 26 0.3× 39 412
Bianca Grosser Germany 13 123 0.4× 119 0.5× 155 1.3× 75 0.6× 81 0.9× 35 352
Cécile Jovelet France 11 222 0.7× 246 1.0× 200 1.6× 136 1.1× 24 0.3× 31 416
Coraline Duménil France 9 235 0.7× 135 0.6× 427 3.5× 124 1.0× 32 0.4× 20 545

Countries citing papers authored by Cameron Herberts

Since Specialization
Citations

This map shows the geographic impact of Cameron Herberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Herberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Herberts more than expected).

Fields of papers citing papers by Cameron Herberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Herberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Herberts. The network helps show where Cameron Herberts may publish in the future.

Co-authorship network of co-authors of Cameron Herberts

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Herberts. A scholar is included among the top collaborators of Cameron Herberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Herberts. Cameron Herberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fadlullah, Muhammad Zaki Hidayatullah, David A. Nix, Cameron Herberts, et al.. (2025). Multi-gene risk score for prediction of clinical outcomes in treatment-naïve metastatic castrate-resistant prostate cancer. JNCI Cancer Spectrum. 9(2).
2.
Bacon, Jack V. W., Cameron Herberts, Cecily Q. Bernales, et al.. (2025). Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma. npj Precision Oncology. 9(1). 177–177. 1 indexed citations
3.
4.
Tolmeijer, Sofie H., Takayuki Sumiyoshi, Edmond M. Kwan, et al.. (2023). Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 29(15). 2835–2844. 26 indexed citations
5.
Ritch, Elie, Cameron Herberts, Evan W. Warner, et al.. (2023). A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes. npj Precision Oncology. 7(1). 27–27. 6 indexed citations
6.
Herberts, Cameron, Alexander W. Wyatt, Paul L. Nguyen, & Heather H. Cheng. (2023). Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair. American Society of Clinical Oncology Educational Book. 43(43). e390384–e390384. 11 indexed citations
7.
Herberts, Cameron, Corinne Maurice‐Dror, Daniel Khalaf, et al.. (2023). Machine-learning to predict utility of circulating tumor DNA (ctDNA) for somatic genotyping.. Journal of Clinical Oncology. 41(6_suppl). 232–232.
8.
Maurice‐Dror, Corinne, Cameron Herberts, Edmond M. Kwan, et al.. (2022). Biallelic loss of TP53, PTEN, and RB1 in association to aggressive clinical features and poor outcomes in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 40(16_suppl). 5055–5055. 2 indexed citations
9.
Eecken, Kim Van der, Cameron Herberts, Sofie Verbeke, et al.. (2022). Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer. JCO Precision Oncology. 6(6). e2100543–e2100543. 5 indexed citations
10.
Annala, Matti, Sinja Taavitsainen, Daniel Khalaf, et al.. (2021). Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clinical Cancer Research. 27(16). 4610–4623. 52 indexed citations
11.
Warner, Evan W., Cameron Herberts, Simon Fu, et al.. (2021). BRCA2 , ATM , and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression. Clinical Cancer Research. 27(6). 1650–1662. 52 indexed citations
12.
Bacon, Jack V. W., David C. Müller, Elie Ritch, et al.. (2021). Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy. European Urology Oncology. 5(6). 677–686. 12 indexed citations
13.
Herberts, Cameron & Alexander W. Wyatt. (2021). Technical and biological constraints on ctDNA-based genotyping. Trends in cancer. 7(11). 995–1009. 41 indexed citations
14.
Maurice‐Dror, Corinne, et al.. (2021). Circulating tumor DNA fraction (ctDNA%) to independently predict for clinical outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 39(15_suppl). 5049–5049. 2 indexed citations
15.
Genitsch, Vera, Attila Kollár, Gillian Vandekerkhove, et al.. (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 37(9). 573.e19–573.e29. 33 indexed citations
16.
Genitsch, Vera, Attila Kollár, Gillian Vandekerkhove, et al.. (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 37(11). 826–836. 32 indexed citations
17.
Vandekerkhove, Gillian, Werner J. Struss, Matti Annala, et al.. (2019). Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. European Urology. 75(4). 667–675. 134 indexed citations
18.
Fu, Songbin, Andrew J. Murtha, Cameron Herberts, et al.. (2019). Activating mutations in AKT1/PIK3CA are associated with poor clinical outcomes in metastatic prostate cancer (mPC). Annals of Oncology. 30. v347–v347. 1 indexed citations
19.
Khalaf, Daniel, Cameron Herberts, Gillian Vandekerkhove, et al.. (2018). Determining biomarkers of response to docetaxel for patients with metastatic castration-resistant prostate cancer (mCRPC) using circulating cell-free tumor DNA (ctDNA).. Journal of Clinical Oncology. 36(6_suppl). 260–260. 1 indexed citations
20.
Chedgy, Edmund C.P., Gillian Vandekerkhove, Cameron Herberts, et al.. (2018). Biallelic tumour suppressor loss and DNA repair defects in de novo small‐cell prostate carcinoma. The Journal of Pathology. 246(2). 244–253. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elie Ritch Breakdown of academic impact, for papers by Gianluca Gragnano Breakdown of academic impact, for papers by Sergi Clavé Breakdown of academic impact, for papers by Mariantonia Nacchio Breakdown of academic impact, for papers by J.B. Auliac Breakdown of academic impact, for papers by Adam Szpechciński Breakdown of academic impact, for papers by Yalun Li Breakdown of academic impact, for papers by Bianca Grosser Breakdown of academic impact, for papers by Cécile Jovelet Breakdown of academic impact, for papers by Coraline Duménil
Rankless by CCL
2026